Africa's pharmaceutical market faces supply chain issues and counterfeit drugs, but technology offers a solution. Leveraging digital tools can address these challenges, create economic opportunities, and strengthen healthcare infrastructure - making a lasting positive impact on public health and economic growth.
Prosper Africa, a Presidential-level national security initiative focused on strengthening strategic and economic ties between the U.S. and Africa, has launched a pilot project under its Africa Tech for Trade Alliance (AT4T). The initiative, announced on November 12, aims to digitize and improve transparency in Africa’s pharmaceutical supply chains. Launched in collaboration with USAID’s e-Trade Alliance, IBM Consulting, and the National Association of Boards of Pharmacy (NABP), it introduces the Pulse by NABP™ platform in South Africa.
British Robinson, Coordinator of Prosper Africa, highlighted the importance of partnerships in developing technology-driven solutions under the Digital Trade for Africa (DTA) initiative. “Through Prosper Africa’s Tech for Trade Alliance, we support partnerships that leverage technology to create products that yield both financial and social benefits for Africans and Americans alike,” he stated.
Designed to link U.S. and global pharmaceutical giants like Pfizer and Roche with African distributors and pharmacies, Pulse by NABP™ aims to foster transparency, improve communication, and establish a secure framework for medication distribution.
This initiative also includes AI-based training for African pharmacies and retailers through IBM’s watsonx.ai, empowering them with data-driven tools to optimize their sales strategies. The Pulse platform is set to address Africa’s complex pharmaceutical distribution challenges, paving the way for increased economic growth and access to healthcare across the continent.
Africa has one of the fastest-growing pharmaceutical markets in the world, valued at approximately $26.85 billion in 2023, according to the Africa Pharmaceutical Market Size, Industry Report, 2030 by research and consulting company Grand View Research. This market is expected to expand at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2030, fueled by an increasing demand for healthcare services as the population grows and ages.
However, the continent faces challenges, including fragmented supply chains, logistical barriers, and regulatory differences, which drive up costs and reduce product availability. The Pulse platform aims to address these challenges by increasing supply chain visibility, which could help African pharmacies minimize losses, maintain consistent stock, and forge profitable partnerships with international suppliers.
The initiative aligns with recommendations outlined in the African Development Bank Group's 2022 report, A New Frontier for African Pharmaceutical Manufacturing Industry. The report emphasizes that strengthening logistics integration is essential to developing Africa’s pharmaceutical industry, enabling efficient intra-African and international trade, particularly in pharmaceutical products.
Hikmatu Bilali
